Registry Measuring the Impact of Adding RNA Expression Testing on Referral Decisions in Early Stage Lung Cancer Patients and Assessing the Disease-free Survival With Long-term Follow-up
Clinical trial NCT02121925 · TERMINATED
Trial details
- NCT number
- NCT02121925
- Sponsor
- Myriad Genetic Laboratories, Inc.
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2014-05-01
- Primary completion
- 2017-06-30
- Enrollment
- 227
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.